SmallCap
CompaniesMapStatistics

(주)카이바이오텍

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Stock Code: 446600

Company Name(주)카이바이오텍
English NameKaiBioTech Co., Ltd
Business Reg. No.4188142520
CEO김영덕
Address전라북도 전주시 덕진구 백제대로567(금암동)
Industry합성의약품 및 기타 완제 의약품 제조업
Industry Code212
Main Products방사성 진단,치료 의약품 제조
Established20121218
Phone063-219-5510
Websitewww.kaibiotech.com/
Regular EmployeesContact
Corp. Reg. No.2101110087512

Investment Metrics


Market Cap
-
Op. Margin
-7.07%
ROE
164.83%
Debt Ratio
-3,144.98%

Certification Status


Venture Certified

Cert. History
기술평가보증기업(기금)2014-04-11 ~ 2016-04-10201401041462014-04-11
연구개발유형2016-04-11 ~ 2018-04-10201601040312014-04-11
연구개발유형2018-04-11 ~ 2020-04-10201801037432014-04-11
벤처투자유형2020-04-11 ~ 2022-04-10202003003602014-04-11
벤처투자유형2022-04-11 ~ 2025-04-10202204280100362014-04-11
벤처투자유형2025-04-11 ~ 2028-04-10202504300100142014-04-11

Financial Statements


3-Year Financial Data

Revenue CAGR +7.5%

Item202420232022
Revenue

52B

46B

45B

Operating Profit

-3.7B

-2.0B

-5.0B

Net Profit

-2.3B

-2.9B

-5.7B

Total Assets

43B

45B

46B

Total Liabilities

44B

44B

44B

Total Equity

-1.4B

0.9B

2.6B

Risk Indicators


3 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
52B

14.0%

vs. 3-Year Avg.: 45B
Operating Profit
-4B

4.8%

vs. 3-Year Avg.: -4B
Op. Margin
-7.1%

8.7%

vs. 3-Year Avg.: -7.7%
Debt Ratio
-3145.0%

197.3%

vs. 3-Year Avg.: 3233.8%
ROE
164.8%

161.5%

vs. 3-Year Avg.: -268.1%

Officers / Major Shareholders


ShareholderOwnership (%)Shares Held
-
-
-
-

Employment Status


Regular EmployeesContact
CEO김영덕

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "전북 전주시",
  "ceo_name": "김영덕",
  "certificate": [
    {
      "cert_number": "20140104146",
      "changes": "",
      "disclosure_date": "2014-04-11",
      "first_cert_date": "2014-04-11",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-04-11 ~ 2016-04-10"
    },
    {
      "cert_number": "20160104031",
      "changes": "",
      "disclosure_date": "2016-04-08",
      "first_cert_date": "2014-04-11",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2016-04-11 ~ 2018-04-10"
    },
    {
      "cert_number": "20180103743",
      "changes": "",
      "disclosure_date": "2018-04-05",
      "first_cert_date": "2014-04-11",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2018-04-11 ~ 2020-04-10"
    },
    {
      "cert_number": "20200300360",
      "changes": "",
      "disclosure_date": "2020-03-26",
      "first_cert_date": "2014-04-11",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2020-04-11 ~ 2022-04-10"
    },
    {
      "cert_number": "20220428010036",
      "changes": "",
      "disclosure_date": "2022-04-28",
      "first_cert_date": "2014-04-11",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2022-04-11 ~ 2025-04-10"
    },
    {
      "cert_number": "20250430010014",
      "changes": "",
      "disclosure_date": "2025-04-30",
      "first_cert_date": "2014-04-11",
      "no": "6",
      "type": "벤처투자유형",
      "valid_period": "2025-04-11 ~ 2028-04-10"
    }
  ],
  "company_name": "(주)카이바이오텍",
  "corp_no": "210111-*******",
  "financials": {
    "2022": {
      "capital_stock": 5360955000,
      "cost_of_sales": 3316482000,
      "current_assets": 2429122000,
      "current_liabilities": 1097058000,
      "gross_profit": 1167031000,
      "net_income": -571495000,
      "net_income_bs": -571495000,
      "non_current_assets": 2185142000,
      "non_current_liabilities": 3258629000,
      "non_operating_expenses": 123288000,
      "non_operating_income": 55120000,
      "operating_profit": -503327000,
      "revenue": 4483512000,
      "sga_expenses": 1670357000,
      "total_assets": 4614264000,
      "total_equity": 258576000,
      "total_liabilities": 4355688000
    },
    "2023": {
      "capital_stock": 5360955000,
      "cost_of_sales": 4131357000,
      "current_assets": 2558733000,
      "current_liabilities": 4207129000,
      "gross_profit": 480518000,
      "net_income": -289051000,
      "net_income_bs": -289050000,
      "non_current_assets": 1918272000,
      "non_current_liabilities": 178193000,
      "non_operating_expenses": 127367000,
      "non_operating_income": 35141000,
      "operating_profit": -196825000,
      "revenue": 4611875000,
      "sga_expenses": 677343000,
      "total_assets": 4477004000,
      "total_equity": 91683000,
      "total_liabilities": 4385321000
    },
    "2024": {
      "capital_stock": 5360955000,
      "cost_of_sales": 4877570000,
      "current_assets": 2592312000,
      "current_liabilities": 1191269000,
      "gross_profit": 308440000,
      "net_income": -233095000,
      "net_income_bs": -233095000,
      "non_current_assets": 1713652000,
      "non_current_liabilities": 3256107000,
      "non_operating_expenses": 112022000,
      "non_operating_income": 245737000,
      "operating_profit": -366810000,
      "revenue": 5186010000,
      "sga_expenses": 675250000,
      "total_assets": 4305965000,
      "total_equity": -141412000,
      "total_liabilities": 4447377000
    }
  },
  "industry": "합성의약품 및 기타 완제 의약품 제조업",
  "investment": [
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2019-07-29"
    },
    {
      "amount": "1,000,010,000",
      "changes": "1,000,010,000",
      "date": "2019-07-29"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2019-06-28"
    },
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2016-09-12"
    },
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2016-09-12"
    }
  ],
  "main_products": "방사성 진단,치료 의약품 제조",
  "phone": "063-219-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: DART | Section Coverage: 6/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Not Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
DART Financial2026-02-27
Collected
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Venture System Detail2026-02-25
Collected